|77.37||-0.46 / -0.59%|
Data as of 4:02pm ET
|77.37||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 133.50, with a high estimate of 144.00 and a low estimate of 123.00. The median estimate represents a +72.55% increase from the last price of 77.37.
The current consensus among 4 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.